← All Authorities
United States Leading Case causation factual

Dura Pharmaceuticals Inc v Broudo

544 U.S. 336 (2005)
JurisdictionUnited States
CourtUS Supreme Court
Year2005
StatusBinding authority

Summary

A securities fraud plaintiff must plead and prove loss causation, showing the defendant's misrepresentation caused actual economic loss, not merely an inflated purchase price.

Key Principle

A securities fraud plaintiff must prove that the defendant's misrepresentation caused an economic loss, not merely an inflated purchase price.

Area of Law

securities

Related Cases

China Trends Holdings Ltd v Stock Exchange of Hong Kong Ltd [2026] HKCFI 783

Court upholds Stock Exchange of Hong Kong delisting decisions where properly made, affirming deference to exchange regulatory decisions.

HKSAR v Mak Kwong Yiu & Ors [2025] HKCFA 20

CFA clarified the conditions under which disclosure obligations arise under the Hong Kong Stock Exchange Listing Rules in a securities context.

Christine Ruth Ong Chai Hoon v Lam Kin Chung [2025] HKCFI 3857

HK Court of First Instance dismissed investors' misrepresentation claims arising from alleged false statements made in connection with a software company IPO.

Ask CommonBench about this case

Get a detailed analysis of Dura Pharmaceuticals Inc v Broudo and how it applies to your situation.

Explain Dura Pharmaceuticals Inc v Bro...